Subject: Market Is Buoyed by Technology, Bank, Medical-Field Issues; Nasdaq Index Up 
Date: Published: 6/16/93 (27 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    OTC Focus:
    Market Is Buoyed by Technology, Bank,
    Medical-Field Issues; Nasdaq Index Up
    ----
    By Sara Calian
    Staff Reporter of The Wall Street Journal

[32 lines irrelevant to AIDS omitted.  --sysop]

    Amgen jumped 1 1/8 to 36.  Prudential Securities biotechnology
 analyst Joseph Edelman said fears of a decline in sales growth of
 Amgen's flagship product have been overblown.  He said the potential
 for the company's products under development has been
 underestimated.  He reiterated his "buy" recommendation and
 designated the stock his "single best idea" in the biotech group.
 Mr. Edelman said the long-term growth of Neupogen is ensured as the
 drug moves beyond its current chemotherapy uses into treatment of
 infectious diseases, such as AIDS and pneumonia.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]